 |
azacitidine |
|---|---|
| Trade Name | Vidaza |
| Orphan Indication | Myelodysplastic syndromes |
| USA Market Approval | USA |
| USA Designation Date | 2001-12-03 00:00:00 |
| Sponsor | Celgene Corporation;9900 W. 109th Street, Suite 300;Overland Park, Kansas, 66210 |
| |
azacitidine |
|---|---|
| Trade Name | Vidaza |
| Orphan Indication | Myelodysplastic syndromes |
| USA Market Approval | USA |
| USA Designation Date | 2001-12-03 00:00:00 |
| Sponsor | Celgene Corporation;9900 W. 109th Street, Suite 300;Overland Park, Kansas, 66210 |